Boston Scientific

Boston Scientific

BSX
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

BSX · Stock Price

USD 56.00-13.48 (-19.40%)
Market Cap: $85.3B

Historical price data

Overview

Boston Scientific is a diversified medical device leader with a mission to advance science for life by delivering innovative, minimally invasive solutions. The company has achieved sustained growth through strategic diversification beyond its cardiovascular roots into high-growth areas like neuromodulation and endoscopy, supported by a robust R&D engine and strategic acquisitions. Its strategy focuses on addressing unmet clinical needs with category-leading technologies, driving global expansion, and improving patient outcomes while delivering shareholder value.

CardiovascularNeuromodulationEndoscopyOncologyUrologyPelvic Health

Technology Platform

A diversified portfolio of minimally invasive technology platforms including advanced delivery systems, implantable devices, energy-based therapeutics, advanced imaging, drug-eluting technologies, and digital health connectivity.

Opportunities

Major near-term growth is driven by the global launch of the FARAPULSE Pulsed Field Ablation system, which is poised to capture significant share in the large atrial fibrillation market.
Long-term opportunities include expansion in high-growth endoscopy (single-use scopes) and neuromodulation markets, supported by demographic trends favoring minimally invasive therapies.

Risk Factors

Key risks include intense competition from larger rivals like Medtronic and Abbott, potential regulatory delays for pipeline products, pricing pressure from global healthcare systems, and execution risks associated with integrating acquired technologies and commercializing new platforms.

Competitive Landscape

Boston Scientific competes in concentrated markets against medtech giants like Medtronic, Abbott, and Johnson & Johnson. Its strategy involves entering established markets with differentiated, later-generation technologies (e.g., pulsed field ablation, single-use endoscopy) to gain share, leveraging its strong physician relationships and global commercial scale.